+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GalNAc-siRNA Conjugates Market - Global Forecast 2025-2030- Product Image
GalNAc-siRNA Conjugates Market - Global Forecast 2025-2030- Product Image
Sale

GalNAc-siRNA Conjugates Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120848
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The GalNAc-siRNA conjugates market is entering a pivotal growth phase as precision medicine reshapes strategic decision-making. Senior executives face a fast-evolving landscape fueled by innovation in RNA interference and glycosylation chemistry, with product differentiation and operational agility emerging as critical levers for sustained competitive advantage.

Market Snapshot: GalNAc-siRNA Conjugates

This market is characterized by robust momentum due to notable breakthroughs in glycan engineering and delivery technology. Accelerated clinical trials across a range of liver-based indications and cross-sector collaborations drive steady expansion. The sector benefits from consistent venture investment and the convergence of research, manufacturing, and commercialization expertise. High-throughput screening and advanced medicinal chemistry enhance the efficiency of development pipelines, while adaptive regulatory frameworks in regions such as the Americas and Asia-Pacific expedite pathway to market.

Scope & Segmentation of the GalNAc-siRNA Conjugates Market

Decision-makers can leverage this report’s in-depth segmentation and regional insight for optimized strategy development:

  • Product Types: Biantennary, Monoantennary, Triantennary configurations—each defined by distinct glycan architectures to optimize receptor binding and streamline manufacturing efficiency.
  • Indications: Acute Hepatic Porphyria, Homozygous Familial Hypercholesterolemia, Primary Hyperoxaluria Type 1, and Transthyretin-Mediated Amyloidosis—target indications offering differentiated advantages in hepatic gene silencing.
  • End Users: Hospitals, Research Organizations, and Specialty Clinics—each presenting unique requirements across clinical practice and investigational protocols.
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies—key for optimizing patient access and aligning with institutional or direct-to-patient delivery preferences.
  • Formulation Variants: Lyophilized Powder, Solution presentations—enabling flexibility in shelf life management and suitability across diverse clinical workflows.
  • Regions Covered: Americas (including the United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (select countries such as the United Kingdom, Germany, and Saudi Arabia, among others), and Asia-Pacific (including China, India, Japan, and several Southeast Asian nations).
  • Key Companies Analyzed: Alnylam Pharmaceuticals, Inc.; Novartis AG; Novo Nordisk A/S; Dicerna Pharmaceuticals, Inc.; Silence Therapeutics plc; Arrowhead Pharmaceuticals, Inc.

Key Takeaways for Senior Decision-Makers

  • Triantennary glycan scaffolds deliver higher receptor affinity and enable less frequent dosing, which can streamline patient management and resource utilization.
  • The strategic refinement of cleavable linker chemistries enhances the intracellular release profile, supporting more reliable gene silencing outcomes and potential gains in clinical performance.
  • Flexible formulation options accommodate logistics requirements, with lyophilized powders ensuring extended stability and solutions reducing clinical preparation time.
  • Segmentation reveals that specialty clinics and hospital pharmacies are pivotal for personalized patient pathways and robust supply chain infrastructure.
  • Expanded real-world clinical deployment and adaptive trial approaches increase confidence in tailoring therapeutic strategies for rare hepatic conditions.

Tariff Impact: Effects on Supply Chains and Innovation

Newly implemented United States tariffs in 2025 affect biotech procurement strategies by increasing import costs on essential oligonucleotide materials. Manufacturers are adopting cost-mitigation strategies such as localized sourcing and investment in modular production platforms. These changes prompt process improvements in synthesis and validation while reinforcing the need for resilient supply relationships and digitalized inventory management. Cross-border partnerships are adapting with risk-sharing and joint-venture models to address evolving market conditions.

Methodology & Data Sources

This market analysis synthesizes data from secondary research, including peer-reviewed publications, patent filings, and clinical registries, alongside primary interviews with subject matter experts. Data triangulation and cross-verification protocols ensure findings’ accuracy, with qualitative insights substantiated by public trial results and regulatory updates.

Why This Report Matters for Strategic Leaders

  • Enables robust portfolio planning and early identification of technology trends in GalNAc-siRNA conjugates.
  • Equips teams to navigate emerging regional dynamics, regulatory shifts, and post-tariff supply chain realignments effectively.

Conclusion

GalNAc-siRNA conjugates represent a crucial direction in targeted gene silencing, integrating advanced glycan and delivery innovations. Strategic adoption of these insights supports clinical and operational goals, positioning organizations to lead in precision RNA therapeutics.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of advanced endosomal escape enhancers to boost GalNAc-siRNA therapeutic efficacy
5.2. Optimization of scalable continuous flow synthesis methods for industrial GalNAc-siRNA production
5.3. Clinical trial momentum in chronic liver disease using next-generation multivalent GalNAc-siRNA conjugates
5.4. Development of novel ligand scaffolds to enhance receptor-mediated uptake of GalNAc-siRNA therapies
5.5. Emergence of biosimilar GalNAc-siRNA candidates challenging patent exclusivity and pricing models
5.6. Regulatory guidance evolution for accelerated approval pathways targeting rare genetic disorders with GalNAc-siRNA
5.7. Strategic partnerships between biotech and CMOs to establish end-to-end GalNAc-siRNA manufacturing ecosystems
5.8. Advancements in in vivo biodistribution analytics for precise dosing of GalNAc-siRNA conjugate therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. GalNAc-siRNA Conjugates Market, by Product Type
8.1. Introduction
8.2. Biantennary
8.3. Monoantennary
8.4. Triantennary
9. GalNAc-siRNA Conjugates Market, by Indication
9.1. Introduction
9.2. Acute Hepatic Porphyria
9.3. Homozygous Familial Hypercholesterolemia
9.4. Primary Hyperoxaluria Type 1
9.5. Transthyretin-Mediated Amyloidosis
10. GalNAc-siRNA Conjugates Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Research Organizations
10.4. Specialty Clinics
11. GalNAc-siRNA Conjugates Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. GalNAc-siRNA Conjugates Market, by Formulation
12.1. Introduction
12.2. Lyophilized Powder
12.3. Solution
13. Americas GalNAc-siRNA Conjugates Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa GalNAc-siRNA Conjugates Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific GalNAc-siRNA Conjugates Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Alnylam Pharmaceuticals, Inc.
16.3.2. Novartis AG
16.3.3. Novo Nordisk a/S
16.3.4. Dicerna Pharmaceuticals, Inc.
16.3.5. Silence Therapeutics plc
16.3.6. Arrowhead Pharmaceuticals, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GALNAC-SIRNA CONJUGATES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GALNAC-SIRNA CONJUGATES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GALNAC-SIRNA CONJUGATES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GALNAC-SIRNA CONJUGATES MARKET: RESEARCHAI
FIGURE 26. GALNAC-SIRNA CONJUGATES MARKET: RESEARCHSTATISTICS
FIGURE 27. GALNAC-SIRNA CONJUGATES MARKET: RESEARCHCONTACTS
FIGURE 28. GALNAC-SIRNA CONJUGATES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GALNAC-SIRNA CONJUGATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY BIANTENNARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY BIANTENNARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY MONOANTENNARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY MONOANTENNARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY TRIANTENNARY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY TRIANTENNARY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY ACUTE HEPATIC PORPHYRIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY ACUTE HEPATIC PORPHYRIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRIMARY HYPEROXALURIA TYPE 1, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRIMARY HYPEROXALURIA TYPE 1, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 73. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 76. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 77. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 82. CANADA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 83. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 86. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 87. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 136. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 137. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 138. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 139. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 144. GERMANY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 145. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 154. FRANCE GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 165. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 168. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 169. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. ITALY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. SPAIN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 215. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. DENMARK GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 235. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. QATAR GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 248. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 249. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 254. FINLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 275. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 284. EGYPT GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 285. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 294. TURKEY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 305. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 308. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 309. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 314. NORWAY GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 315. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 324. POLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND GALNAC-SIRNA CONJUGATES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND GALNAC-SIRNA C

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this GalNAc-siRNA Conjugates market report include:
  • Alnylam Pharmaceuticals, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Dicerna Pharmaceuticals, Inc.
  • Silence Therapeutics plc
  • Arrowhead Pharmaceuticals, Inc.

Related Reports

GalNAc-siRNA Conjugates Drug Market - Global Forecast 2025-2030 - Product Image

GalNAc-siRNA Conjugates Drug Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
GalNac Conjugates Market - Global Forecast 2025-2030 - Product Image

GalNac Conjugates Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
SiRNA Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

SiRNA Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From
RNAi Technology - Global Strategic Business Report - Product Image

RNAi Technology - Global Strategic Business Report

  • Report
  • 138 Pages
  • Global
From
RNA Interference- Pipeline Insight, 2025 - Product Image

RNA Interference- Pipeline Insight, 2025

  • Drug Pipelines
  • 204 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.